Mass Spectrometry Imaging Platform for Revealing Spatial Metabolic Alterations in Cancer Tissues

Mass Spectrometry Imaging Platform for Revealing Spatial Metabolic Alterations in Cancer Tissues

Mass Spectrometry Imaging Platform for Revealing Spatial Metabolic Alterations in Cancer Tissues


Dr. Panayiotis Vacratsis

University of Windsor


FUNDER: Windsor Cancer Centre Foundation

DURATION: 2025-2026

Related Programs:
Nucleus Cores:

This project will establish a cutting-edge Mass Spectrometry Imaging (MSI) platform using Matrix-Assisted Laser Desorption/Ionization (MALDI) to visualize the spatial distribution of metabolites in cancer tissues. Researchers will optimize the workflow on a newly upgraded SYNAPT G2-Si mass spectrometer and apply it to a mouse model of colorectal cancer. By comparing tissue samples from mice on time-restricted feeding (TRF) and standard diets, the team aims to uncover how TRF impacts the metabolic environment of tumours. The platform will support a range of studies in metabolomics, lipidomics, and drug distribution, and generate pilot data to strengthen future funding applications and interdisciplinary collaborations.

This project will enable access to high-resolution spatial metabolomics for advanced tissue analysis in cancer research. Insights gained may inform cancer prevention strategies through dietary interventions like time-restricted feeding.

Co-Applicants:

University of Windsor

  • Dr. Phillip Karpowicz

Collaborators:

Schulich School of Medicine & Dentistry

  • Dr. Christopher Bonham
Loading...